Latest Bioethics Stories
Evidence In Motion releases Called To Care, a course that focuses on the non-clinical factors that impact patient outcomes. (PRWEB) November 14, 2013
Preclinical Testing at Icahn School of Medicine at Mount Sinai Shows SUMO-1 Gene Therapy Shrinks an Enlarged Heart, Improves Heart Function, and Blood Flow New
Remarkable improvements in the quality of life, prevention and treatment of disease have been made possible through advancements in biomedical research, including clinical trials involving human subjects.
Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload.
Creighton University bioethics professor, Amy Haddad, Ph.D., receives honor of being named President-Elect of the American Society of Bioethics and Humanities. Omaha,
Evidence in Motion Executives Write Article Published in the Journal of Orthopaedic & Sports Physical Therapy Exploring the Placebo and Nocebo Phenomena, Their Effect On Patient Outcomes,
Co-founder and President Barbara Netter thanks donors for supporting ground-breaking and life-saving research.
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A poem in which the author retracts something said in an earlier poem.
More Images (1 images) »